New Packaging Technologies Displayed at INTERPHEX - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New Packaging Technologies Displayed at INTERPHEX
Highlights included the latest in pharmaceutical packaging equipment, containers, and labels and new capabilities among contract service providers.


Pharmaceutical Technology
Volume 36, Issue 6, pp. 32-35

Contract services

Contract manufacturers and packagers are investing in their operations to meet rising demand. Several firms have added capacity for filling solid dosage forms in bottles (A+ Secure Packaging, Almac, Pharma Packaging Solutions, Reed-Lane).

Contact manufacturers have also invested in new lines dedicated to blister packaging. One blister line integrates blister foil printing, checkweighing and vision inspection. The 200-per-minute line handles a range of materials, including polyvinyl chloride (PVC), PVC/polyvinylidene chloride, Aclar, and aluminum/aluminum (UPS 4 blister line from Uhlmann, installed at Almac).

A UK-based specialist in clinical trials and small batches has installed an aseptic vial line for small-volume parenterals. The line primarily fills volumes ranging from 2–20 mL, but could handle vials up to 100 mL (SCM Pharma).

A year-old stick-packaging line forms, fills, and seals 400 mg to 3 g of moisture-sensitive pharmaceuticals and probiotics in narrow, foil-laminate packs. Especially well-suited to products for pediatric and geriatric populations that are intended to be mixed with food, the fully integrated line operates in a humidity- and temperature-controlled environment. Rated at 1000 packs per minute, the line doses 10 packs at a time and loads finished packs into 7-, 14-, 28- or 56-count cartons (Stick-pack contract packaging service, Ropack).

An on-site, visual inspection service provides equipment, certified technicians, and service without the capital investment, integration, maintenance, and training issues associated with purchasing equipment. With several models available, equipment can be matched to the application and installed in line or as a standalone unit. Scalable contracts adjust to changes in usage (contract inspection service utilizing Viswill (formerly Kanebo) equipment, Visionspect Division of Daiichi Jitsugyo Viswill)


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here